TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bio-Works Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
26,262
|
44,468
|
39,135 |
| Financial expenses |
9
|
2
|
19 |
| Earnings before taxes |
-36,317
|
-52,671
|
-39,533 |
| EBITDA |
-36,009
|
-52,924
|
-39,880 |
| Total assets |
22,613
|
24,901
|
39,402 |
| Current assets |
20,739
|
22,380
|
37,101 |
| Current liabilities |
7,481
|
15,784
|
20,199 |
| Equity capital |
15,132
|
9,117
|
19,203 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
31
|
33
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.9%
|
36.6%
|
48.7% |
| Turnover per employee |
847
|
1,348
|
1,118 |
| Profit as a percentage of turnover |
-138.3%
|
-118.4%
|
-101.0% |
| Return on assets (ROA) |
-160.6%
|
-211.5%
|
-100.3% |
| Current ratio |
277.2%
|
141.8%
|
183.7% |
| Return on equity (ROE) |
-240.0%
|
-577.7%
|
-205.9% |
| Change turnover |
-19,008
|
2,556
|
18,360 |
| Change turnover % |
-42%
|
6%
|
88% |
| Chg. No. of employees |
-2
|
-2
|
8 |
| Chg. No. of employees % |
-6%
|
-6%
|
30% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.